Susan Mulvaney

Susan Mulvaney has extensive experience in the legal field, with a focus on contracts and intellectual property. Susan currently holds the position of Senior Director, Intellectual Property & Contracts Counsel at Karuna Therapeutics, where they have been employed since 2022. Prior to this, they worked as an Associate Director, Contracts Counsel at Acceleron Pharma in 2021.

From 2019 to 2021, Susan served as the Sr. Director of Legal Affairs at MediSix Therapeutics, Inc., where they were responsible for establishing contract templates and processes. Before that, they worked as a Contracts Attorney at BlueRock Therapeutics, LLC in 2019, drafting and negotiating various corporate contracts.

In 2018, they were the Sr. Director of Legal Affairs at ANALGESIC SOLUTIONS, LLC, where they not only handled contract negotiations but also developed and executed intellectual property strategies.

From 2012 to 2017, Susan held the position of Sr. Director of Legal Affairs at Hydra Biosciences, where they oversaw patent strategy and managed external law firms. Prior to that, they worked as a Staff Attorney at Aptiv Solutions from 2008 to 2012 and as a Paralegal at Lando & Anastasi, LLP in 2008.

Susan's early career includes roles at United Therapeutics as an Intellectual Property Manager & Business Analyst from 2003 to 2007, and at AltaRex Corp. as an Intellectual Property & Business Development Associate from 2000 to 2003.

Overall, Susan Mulvaney's work experience demonstrates their expertise in contracts, intellectual property strategy, and legal management.

Susan Mulvaney attended Dean College from 1993 to 1995 and earned an A.Sc. degree in Engineering. Susan then went on to attend New England Institute of Technology from 1997 to 2000, where they obtained a B.Sc. degree in Business Management. Lastly, they attended Suffolk University Law School from 2007 to 2011 and earned a J.D. degree with a concentration in Intellectual Property.